(Q40996460)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806738%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

Interleukin-12 induces an effective antitumor response in malignant mesothelioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806738%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806738%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

Venetsanakos E

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806738%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Leong CC

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806738%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Garlepp MJ

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806738%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Scott B

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806738%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Robinson BW

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806738%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806738%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory Cell and Molecular Biology

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806738%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806738%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806738%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

738-746

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9806738%20AND%20SRC:MED&resulttype=core&format=json

Wittenoom, Western Australia: a modern industrial disaster

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Conventional Treatment and its Effect on Survival of Malignant Pleural Mesothelioma in Western Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Establishment of a murine model of malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Regulation of human cytolytic lymphocyte responses by interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Gene therapy for cancer: what have we done and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Cancer antigens: immune recognition of self and altered self

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Nitric oxide is an important mediator for tumoricidal activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Differential antiproliferative effects of combinations of recombinant interferons alpha and gamma on two murine tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

T cell tolerance by clonal elimination in the thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Autoimmune diabetes as a consequence of locally produced interleukin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.5.3257M